Understanding the Impact of the US Presidential Election on Healthcare Policy and Global Business
Please join us for a breakfast program on Tuesday, Nov. 12 featuring an insightful discussion on the implications of the 2024 US Presidential Election for healthcare policy and business worldwide. This exclusive event will feature prominent experts from the healthcare and legal sectors:
Glenn Snyder, Principal at Deloitte, specializing in life sciences and healthcare innovation
Seth Flaum, Partner at Wilson Sonsini, a leading expert in regulatory law and healthcare business strategy
The session will be moderated by Makoto (Mark) Kawai. Mark is the Government Affairs Director at Zimmer Bionet in Japan, and serves as the chair of the Healthcare Committee and the Government Relations Committee at the American Chamber of Commerce in Japan (ACCJ).
With the election of either a Trump or Harris administration, the global healthcare landscape is poised for significant shifts. Our panel will explore key questions, including potential changes to regulatory frameworks, drug pricing policies, and healthcare reform initiatives in the US, and how these developments could affect global markets, including Japan and other key regions.
Capacity = 20